Determination of tadalafil in small volumes of plasma by high-performance liquid chromatography with UV detection

被引:43
作者
Cheng, CL
Chou, CH
机构
[1] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm, Tainan 70101, Taiwan
[2] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 822卷 / 1-2期
关键词
tadalafil; erectile dysfunction; HPLC; pharmacokinetics;
D O I
10.1016/j.jchromb.2005.06.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tadalafil is a potent reversible phosphodiesterase-5 inhibitor used for the treatment of erectile dysfunction. This study describes a simple and sensitive high-performance liquid chromatographic (HPLC) method for the determination of tadalafil in 50 Id of rat plasma. Tadalafil and the internal standard lamotrigine were extracted with 0.5 ml of tert-butyl methyl ether, after the samples alkalinized with 20 mu l of sodium hydroxide solution (IN). Chromatographic separation was achieved on a C18 column with the mobile phase of acetonitrile-water containing 20 mM phosphate buffer (pH 7) (35/65, v/v), at a flow rate of 1 ml/min. The eluant was detected at 290 nm. The retention time was about 4.5 min for lamotrigine and 15 min for tadalafil. No endogenous substances were found to interfere. Calibration curves were linear from 10 to 2000 ng/ml. The recovery of tadalafil from plasma was greater than 77%. The limit of quantitation was 10 ng/ml. The intra- and inter-day imprecision (expressed as coefficient of variation, C.V.) did not exceed 10.7%, and the accuracy was within 5.9% deviation of the nominal concentration. The method is suitable in pharmacokinetic investigation and monitoring tadalafil concentration. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:278 / 284
页数:7
相关论文
共 11 条
[1]   Determination of tadalafil in pharmaceutical preparation by HPLC using monolithic silica column [J].
Aboul-Enein, HY ;
Ali, I .
TALANTA, 2005, 65 (01) :276-280
[2]   Validated method for tadalafil analysis in pharmaceutical preparations by capillary electrophoresis [J].
Ali, I ;
Aboul-Enein, HY .
CHROMATOGRAPHIA, 2004, 60 (3-4) :187-191
[3]   Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography [J].
Cheng, CL ;
Chou, CH ;
Hu, OYP .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 817 (02) :199-206
[4]   Development of a Micellar electrokinetic capillary chromatography method for the determination of three drugs employed in the erectile dysfunction therapy [J].
Flores, JR ;
Nevado, JJB ;
Peñalvo, GC ;
Diez, NM .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 811 (02) :231-236
[5]   Tadalafil: a novel treatment for erectile dysfunction [J].
Giuliano, F ;
Varanese, L .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2002, 4 (0H) :H24-H31
[6]   Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV [J].
Gratz, SR ;
Flurer, CL ;
Wolnik, KA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (03) :525-533
[7]   IC351 (tadalafil, Cialis): update on clinical experience [J].
Porst, H .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (Suppl 1) :S57-S63
[8]   Quantitation of tadalafil in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionization [J].
Ramakrishna, NVS ;
Vishwottam, KN ;
Puran, S ;
Koteshwara, M ;
Manoj, S ;
Santosh, M ;
Chidambara, J ;
Wishu, S ;
Sumatha, B .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 809 (02) :243-249
[9]   Effect of tadalafil on cytochrome P450 3A4-mediated clearance: Studies in vitro and in vivo [J].
Ring, BJ ;
Patterson, BE ;
Mitchell, MI ;
Vandenbranden, M ;
Gillespie, J ;
Bedding, AW ;
Jewell, H ;
Payne, CD ;
Forgue, ST ;
Eckstein, J ;
Wrighton, SA ;
Phillips, DL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) :63-75
[10]  
Sussman David O, 2004, J Am Osteopath Assoc, V104, pS11